Redeye notes a soft Q2 on both sales and EBIT, and we expect a negative share price reaction today of around -5%. Still, we see no reasons for meaningful reconsiderations of our base case or short-term financial forecasts, and we emphasise the company’s excellent long-term prospects.
LÄS MER
